l-carnitine depakote Quantitative systems pharmacology Model to characterize valproic acid-induced hyperammonemia and the effect of supplementation (from 586 mg l L-Carnitine Injection | Kare Pharmacy

Other categories of kidney disease include 1 : Acute kidney disease (AKD) : Kidney damage or dysfunction with a duration of less than three months

VPA was stopped and L-carnitine supplementation (100 mg/kg) was administered intravenously

announced a voluntary recall of the following consumer product

This pathway can be interrupted by the introduction of VPA, which leads to a reduction of free coenzyme A, acetyl-CoA, and carnitine, and results in the decreased availability of cofactors necessary for the function of urea cycle and an increase in NH3 production.[15,16] Because VPA-induced metabolic disorders including hyperammonemia could be mediated at least in part by carnitine deficiency, it has been hypothesized that levocarnitine supplementation may prevent, correct, or attenuate these adverse effects[15,17] Several studies or isolated clinical cases have suggested the potential value of oral levocarnitine in reversing carnitine deficiency or preventing adverse effects due to VPA-induced dysfunction of beta-oxidation